Huiyu Pharmaceutical
PulseAugur coverage of Huiyu Pharmaceutical — every cluster mentioning Huiyu Pharmaceutical across labs, papers, and developer communities, ranked by signal.
2 day(s) with sentiment data
-
Xintian Technology's controlling stake shifts to Shenzhen Yuanqi; Huiyu Pharma wins drug procurement bids
Xintian Technology announced that its controlling shareholder, Shi Weiping, and related parties have signed an agreement to transfer approximately 22.5% of the company's shares to Shenzhen Yuanqi for about 720 million y…
-
Huiyu Pharma receives 5M yuan subsidy; iFlytek patents dialogue control
Huiyu Pharmaceutical has received a government subsidy of 5 million yuan, which represents 20.03% of its net profit from the most recent fiscal year. Separately, iFlytek has patented a method and apparatus for controlli…
-
Shandong Steel Deputy GM Buys Shares, Huiyu Pharma Receives Subsidy
Guo Weida, the deputy general manager of Shandong Steel, has increased his stake in the company. He purchased 95,000 shares for 120,700 yuan on July 7th and plans to acquire at least an additional 300,000 yuan worth of …
-
Jiangshan Oupai Appoints New Board Secretary; Huiyu Pharma's Cancer Drug Trial Accepted
Jiangshan Oupai has appointed Chen Chunjin as the company's board secretary, effective immediately. This move means the company's chairman, Wu Shuigen, will no longer perform the duties of the board secretary. Separatel…